Fatty Acid Quality and Overweight (FO-study)

Fatty Acid Quality and Overweight

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01034436

Enrollment

Registered

2009-12-17

Start date

2009-02-28

Completion date

Unknown

Last updated

2015-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight Reduction and Insulin Sensitivity

Brief summary

The purpose of this study is to study the health effects of fatty acid quality in healthy, overweight individuals.

Interventions

DIETARY_SUPPLEMENTfatty acid quality and overweight

Duration 12 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* no use of medication, healthy, 27\<BMI\<40

Exclusion criteria

* pregnant and lactating women, chronic diseases.

Design outcomes

Primary

Measure	Time frame
Will intake of fat as diacylglycerols give weight reduction in overweight individuals?	baseline (0 weeks), 12 weeks

Secondary

Measure	Time frame
Will a high intake of ALA involve reduced levels of inflammatory markers?	baseline (0 weeks), 12 weeks
Will a high intake of ALA involve changes in insulin sensitivity?	baseline (0 weeks), 12 weeks

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026